A new study suggested that not getting enough REM sleep can be an early warning sign of Alzheimer's disease. Here's what a ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...

The number of Americans diagnosed with Alzheimer’s each year is expected to double by 2060, with the majority of cases affecting women.

Stroke kills millions, but Osaka researchers have unveiled GAI-17, a drug that halts toxic GAPDH clumping, slashes brain ...

A medical breakthrough could soon change how we diagnose one of the most devastating brain diseases of our time. On Bloom, I ...

A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.

A large Finnish project, which is part of the long-term ‘Cardiovascular Risk in Young Finns’ study, found elevated levels of ...

New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly- ...

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

Purple will be the color to wear Thursday. “(The Purple Party) is a really great kickoff for the Walk to End Alzheimer’s ...

Maine researchers are working on a test that could diagnose Alzheimer's disease decades early Donald Trump's approval rating ...